article thumbnail

Vantari VR to introduce virtual right heart catheter training course

Mobi Health News

The training programme was first developed in 2017 by an Australian cardiologist together with Janssen Pharmaceuticals.

article thumbnail

The US Covered Nearly 50% of Global Oncology Medicine Spending in 2017 – a market update from IQVIA

Health Populi

2017 was a banner year of innovative drug launches in oncology, Aitken coined, with more drugs used more extensively, driving improved patient for people dealing with cancer. In the US, spending on oncology doubled from 2012 to 2017, to $50 bn. All oncology products launched in 2017 had list prices above $100,000 per year in the U.S.;

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. in 2017 to as low as $0.19 The Committee to Restore Nymox Shareholder Value, Inc. in 2011 and $5.00 on June 30, 2023.

article thumbnail

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Digital Health Global

Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably. Since 2017, Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.

article thumbnail

The United States of Diabetes: a $1,240 Tax on Every American

Health Populi

Pharmaceutical company executives are testifying in the U.S. The top line of this study is that the economic burden of diabetes overall was $404 billion in 2017. The diabetes economy equated to $1,240 for every American in 2017. Here is the people story underneath these numbers: in 2017, 24.7 bn for prediabetes, and $1.6

article thumbnail

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

Healthcare IT Today

Founded in 2017 as an AI research company, Unlearn has always been at the forefront of developing innovative AI-based solutions for clinical trials. Unlearn’s technology powers the clinical trials of leading global pharmaceutical companies, helping them to reach full enrollment faster and bring new treatments to patients sooner.